站在"十五五"新程待启的关键时点，如何看待2026年的经济形势？2026年经济工作怎么干？新京报贝壳财经推出《看2026：十五五·启新程》专题报道，汇 聚监管部门、知名学者和领军企业家，解读政策脉络，洞察趋势变化。 对于企业而言，针对中央经济工作会议提出的持续扩大内需等议题会有哪些举措？2026年有哪些战略发展目标？新京报贝壳财经记者就此采访了强联智创创 始人、董事长、总经理秦岚。 围绕高端医疗装备对可靠性、稳定性和一致性的严格要求，强联智创将把产品创新与制造体系建设同步推进。公司将依托神经血管疾病智能诊疗装备智能产 线建设项目，系统整合核心算法、关键部件、仿真模型与先进制造工艺，推动研发成果在中试验证、工艺优化和规模化生产中的高效转化。通过智能化、模 块化和标准化的生产体系建设，不断提升产品迭代效率和交付能力，形成支撑企业持续增长的高质量供给基础。 在已有技术成果和产品体系基础上，强联智创将进一步挖掘存量资源的综合价值。依托智能产线和既有产品平台，公司将加强与国家神经疾病医学中心、重 点医院、高校及科研机构的协同合作，推动产品在临床应用、教学培训和科研验证中的多场景复用，通过真实世界数据反哺产品优化和工艺改 ...

Core Viewpoint - The 2025 China International Service Trade Fair features a health and hygiene services section that showcases innovations in the health industry, highlighting the strong momentum of health industry upgrades in China [1]. Group 1: Health Technology Innovations - The "优促计划" theme exhibition, organized by the Beijing Municipal Health Commission, showcases over 50 medical technology achievements, making it one of the most technologically advanced areas of the health services exhibition [2]. - A handheld smart fundus camera demonstrated at the exhibition can quickly capture eye images and identify over 20 types of eye abnormalities using AI, aiding in early detection of eye diseases [2]. - The intelligent refractive screening device and electronic vision chart for children provide efficient eye health screening solutions, developed through collaboration among various institutions, addressing the needs of different age groups [3][4]. Group 2: Project Acceleration and Commercialization - The "优促计划" aims to accelerate the commercialization of medical technology innovations, with a project reserve of 1,371 and a pool of nearly 10,000 experts, resulting in 69 projects being commercialized with a total contract value of 555 million yuan [4]. - The establishment of a national AI application pilot base in the medical field was announced, featuring 14 common service capabilities and 31 AI application scenarios to enhance the health industry [5]. Group 3: AI and Smart Health Solutions - The AI virtual doctor "融融" provides health consultations and triage suggestions, showcasing the integration of AI in patient care and decision-making processes [5]. - A retinal disease and chronic disease warning system, developed by Beijing Tongren Hospital and Eagle Eye Technology, uses AI to assess overall vascular health through retinal imaging, achieving commercial success in multiple community health centers [6]. Group 4: Advanced Medical Equipment - Siemens introduced the world's first photon-counting CT, which has been installed in over 20 hospitals across 15 provinces, with more than 180,000 patient scans completed [7]. - The exhibition featured various high-end medical devices and AI solutions, including the world's first 5.0T whole-body MRI system and an AI catheter shaping robot, showcasing significant advancements in medical technology [7]. Group 5: Innovative Service Models - Tianjin Pengruili Hospital presented a comprehensive service model that integrates hospital, rehabilitation, and wellness services, demonstrating a multi-faceted approach to healthcare delivery [8]. - The ongoing development of AI and cloud computing technologies is expected to accelerate the transformation of the healthcare industry towards digitalization and personalization, enhancing consumer experiences [8].

Group 1: Event Overview - The 2025 China International Service Trade Fair (CIFTIS) successfully concluded on September 14, showcasing the health and wellness services sector for the fifth consecutive year with the theme "Smart Leading Future, Healthy Life" [1] - The participation rate of Fortune 500 companies reached 54%, with an internationalization rate of 53% [1] - Major global companies such as GE Healthcare, Siemens Healthineers, and Mindray participated, alongside first-time exhibitors like Elsevier and Tianjin Pengruili Hospital [1] Group 2: AI and Medical Innovations - The "AI Fundus Camera," developed by Tongren Hospital and Yingtong Technology, allows for rapid retinal imaging and risk assessment for chronic diseases using AI technology [2] - The "Qinghua Chang Geng AI Hepatobiliary Super Doctor," developed by Tsinghua University and Qinghua Huabao, provides intelligent consultations and treatment recommendations for liver and biliary diseases [3] - The AI application base in Beijing aims to enhance medical services through a comprehensive service system for medical institutions and technology companies [4] Group 3: International Expansion of Medical Device Companies - The CIFTIS serves as a significant platform for showcasing innovations in the service trade sector and promoting international cooperation [5] - Companies like United Imaging have successfully entered high-end markets in over 90 countries, achieving a 3.5 times revenue growth in overseas markets from 2020 to 2022 [5] - Mindray Medical has expanded its products and solutions to over 190 countries, with 62 overseas subsidiaries in 40 countries [6] Group 4: Strategic Market Development - Stronglink Intelligent Innovation has initiated its overseas market strategy, achieving progress in AI catheter shaping robot certification and market promotion [7] - The CIFTIS provides a vital opportunity for companies to connect with foreign clients and explore international market opportunities without leaving the country [7]

Core Insights - Beijing Economic-Technological Development Area (Beijing E-Town) has shown impressive economic performance in the first half of 2025, with GDP growth of 12.3% and industrial output surpassing 340 billion yuan, reflecting a strong focus on technological innovation and high-quality development [1][2] Economic Performance - The industrial output value reached 347.87 billion yuan, with a year-on-year growth of 15.6%, significantly outpacing the city's average growth rate of 9.8% [2] - The contribution of industrial added value to the city's economy is approximately 37.7% [2] - Key sectors such as integrated circuits, new energy vehicles, and next-generation information technology are driving this growth [2] Investment and R&D - Fixed asset investment increased by 3.6%, with industrial investment accounting for about three-quarters of the total [4] - R&D expenditures for large and medium-sized enterprises grew by 25.3%, exceeding the city's average growth of 21.2% [4][5] - The establishment of the Beijing Rocket Street, a commercial aerospace research and production base, is expected to enhance the region's innovation capabilities [4] Emerging Industries - New industries and future sectors are rapidly expanding, with significant achievements reported, such as Xiaomi's cumulative delivery of over 300,000 vehicles and the mass production of BOE's sixth-generation semiconductor display devices [2] - The new generation information technology industry achieved an output value of 95.18 billion yuan, growing by 23.6% [2] Service Sector Growth - The productive service industry is experiencing robust growth, with information services generating revenue of 57.39 billion yuan, a year-on-year increase of 23.8% [6] - Financial services also showed strong performance, with net income growth of 31.4% [6] Policy and Ecosystem Development - Beijing E-Town is actively constructing an industrial ecosystem by attracting over 140 biopharmaceutical companies and implementing supportive policies for innovation and talent development [3][7] - The area has introduced various policy measures to enhance enterprise support and foster a modern industrial cluster [7]

Core Viewpoint - The 2025 China International Fair for Trade in Services (CIFTIS) aims to enhance professionalism, marketization, and internationalization, establishing itself as a hub for policy discussions, industry solutions, and corporate innovation in the global service trade sector [1] Group 1: Event Structure and Features - The event will be held annually on the third Tuesday of September for five days, with the first three days dedicated to professional audiences and the last two days open to the public [2] - The venue has shifted from "two locations" to "one location," utilizing Shougang Park to create a "Convention and Exhibition Town," optimizing spatial layout and integrating with the overall planning of the Beijing West area [2] - The event will focus on service trade characteristics, emphasizing digitalization, greening, and standardization, with a significant portion of the exhibition area dedicated to interactive communication spaces [2] Group 2: Themes and Participation - The annual theme "Digital Intelligence Leading, Service Trade Renewed" will guide the event, showcasing new technology applications and solutions across various professional service fields, including digital technology and financial technology [2] - Australia will be the guest country, presenting the largest service trade delegation since the inception of CIFTIS, featuring major companies like ANZ Bank and unicorn enterprises [2][6] - Over 700 enterprises have expressed interest in participating, with more than 30% from outside Beijing, including over 240 Fortune 500 and industry-leading companies [5] Group 3: Forums and Discussions - The event will host 14 thematic forums and 76 specialized forums, with nearly 300 invited speakers, including government leaders and Nobel laureates, discussing topics such as e-commerce development and global green economy [4] - Specialized forums will address industry hot topics, including digital economy cooperation between Nigeria and China, and open cooperation in the telecommunications sector [4] Group 4: Brand and Resource Development - A service brand resource library will be established to enhance visibility for premier service brands, facilitating both online and offline promotional activities [3] - The event will also feature diverse activities, including cultural performances and tourism markets, to promote service consumption integration [3]

Group 1: Industry Overview - Beijing is focusing on developing a "1+4" product system in robotics, which includes humanoid robots, medical health robots, collaborative robots, special robots, and logistics robots, with over 400 core enterprises in the sector [1] - The city has the highest number of specialized "little giant" robot enterprises in the country, with 57 such companies, nearly 30 humanoid robot manufacturers, and 24 registered surgical robots, leading in these metrics nationwide [1] - The robot industry in Beijing generated over 30 billion yuan in revenue in 2024, marking a nearly 50% year-on-year growth [9] Group 2: Technological Advancements - The "TianGong Ultra" humanoid robot won the first global humanoid robot half-marathon, showcasing its long endurance and adaptability to complex terrains, leading to a surge in orders exceeding 2,500 units [2] - The "TianGong 2.0" robot, developed by Beijing Renxing, features industrial-grade capabilities and a smart computing platform, achieving millimeter-level dynamic operation precision [3] - The "HuiSiKaiWu" platform, launched in March 2025, is the world's first general-purpose embodied intelligence platform, integrating AI-driven task planning and data-driven skill execution [4] Group 3: Applications and Use Cases - The "XiaoNuo" robot, developed by Songyan Power, can perform over 200 micro-expressions and is designed for various applications, including education, commercial guidance, and psychological therapy [6] - The AI catheter shaping robot developed by Qianglian Zhichuang can automatically shape catheters for brain surgery, significantly reducing operation time and improving success rates [7] - Robots are being applied in diverse fields such as industrial manufacturing, commercial services, education, medical care, agriculture, and landscaping, with 199 innovative products implemented in 134 application scenarios since 2023 [9] Group 4: Investment and Support - Beijing's government has established a 10 billion yuan robot industry development fund, supported by prominent investment firms, creating a comprehensive investment framework from early-stage R&D to application [10] - The city has a robust public service system, including the National Robot Inspection and Testing Public Service Platform and the World Robot Conference, which has been held successfully for ten years [10]

Group 1 - The article highlights the global debut of the AI catheter shaping robot at the OCIN2025 conference, showcasing advancements in intelligent diagnosis and treatment for cerebrovascular diseases [3][6] - The AI catheter shaping robot, developed in collaboration with leading medical teams, has received China's first "AI + treatment" Class III medical device registration certificate [5] - The robot's live surgery demonstration allowed experts to observe its ability to automatically shape catheters and navigate complex vascular paths, emphasizing the innovation in cerebrovascular intervention surgery [6] Group 2 - Lingyi Biotech presented significant clinical progress on gene therapy drugs for Wilson's disease and Gaucher disease type I at the ASGCT2025 conference, indicating important scientific and clinical implications [8] - Huayi Lekan introduced a novel gene therapy candidate for phenylketonuria (PKU) at ASGCT2025, which utilizes an innovative mechanism to silence mutated PAH genes and restore normal function [11][12] - New gene editing therapy GEN6050X for Duchenne muscular dystrophy (DMD) showed promising biomarker data, suggesting its potential to enhance cardiac function and overall patient outcomes [14] Group 3 - Xibiman Biotech announced early clinical results for C-CAR168, a novel CAR-T therapy targeting refractory lupus nephritis, indicating significant progress in treating autoimmune diseases [15] - The NyokAssist® artificial heart device demonstrated encouraging preliminary results at the ISHLT2025 conference, showcasing its design and low complication rates [18] - Shizai Biotech received approval for clinical trials of a new drug for amyotrophic lateral sclerosis (ALS), marking a significant step in addressing one of the "five major incurable diseases" [20] Group 4 - The establishment of a key laboratory for recombinant protein synthesis in Beijing, co-founded by Yuanwei Technology and Tsinghua University, aims to tackle challenges in the industrial application of synthetic biology [22][24] - Haowei Medical completed the first patient enrollment for a clinical trial of absorbable embolization microspheres for symptomatic uterine fibroids, marking a milestone in interventional treatment in China [26] - Sequoia China has invested in over 200 high-growth medical health companies, with more than 45 successfully completing IPOs across various stock markets [27][28]

Group 1: Event Overview - The 27th China Beijing International Science and Technology Industry Expo successfully concluded on May 11, featuring the theme "Technology Leads to a Creative Future" with six specialized exhibition areas [1] - Over 800 domestic and foreign enterprises and institutions participated in the expo, showcasing various innovative achievements [1] Group 2: AI Integration in Healthcare - AI technology's deep integration with healthcare was a highlight, with surgical robots enhancing grassroots medical capabilities and enabling more precise pain management [1][2] - Stronglink Intelligent Technology Co., Ltd. demonstrated an AI catheter shaping robot for neurointerventional surgery, which assists in path planning and shaping, providing a "navigation" system for surgeons [4] Group 3: Innovations in Pain Management - Beijing New Cloud Medical Technology Co., Ltd. introduced two innovative products, including the AI closed-loop rechargeable spinal cord stimulation system (NewStim), which improves pain management by automatically adjusting stimulation parameters based on nerve feedback [5] - The advancements in AI are expected to allow for earlier intervention and treatment of potential health issues by analyzing spinal cord nerve signals [6] Group 4: Domestic Production and Replacement - The medical industry is making significant strides towards self-sufficiency, with some companies achieving full domestic production and others breaking foreign monopolies in key areas [6] - Beijing Maidis Medical Technology Co., Ltd. showcased an ultrasound-guided electromagnetic positioning puncture device, achieving a 99% success rate in puncture procedures with all components domestically produced [10] Group 5: International Expansion of Innovative Products - Koya Medical Technology Co., Ltd. presented a non-invasive coronary heart disease diagnostic product, the AI coronary CT blood flow reserve measurement, which has received multiple international certifications [14] - The product aims to shift coronary heart disease diagnosis from invasive to non-invasive methods, reducing unnecessary invasive checks [14] - Guanchuan Intelligent Technology Co., Ltd. introduced smart elderly care products that have been exported to several countries, demonstrating strong international competitiveness in both price and technology [15]

金仕生物 全球首款预装干瓣Prostyle A® 获批上市 4月9日，金仕生物宣布由公司自主研发的 Prostyle A®经导管人工主动脉瓣膜置换系统-干法预装可回收输送 系统 获得国家药品监督管理局 （NMPA） 批准上市 （ 国械注准20253130729） 。 作为全球首款预装干瓣，金仕生物推出的新一代介入主动脉瓣Prostyle A®集成了众多瓣膜领域的前沿技 术，拥有干瓣技术、巧妙便捷的预装系统、卓越的瓣膜血流动力学性能和耐久性，优秀的输送性和通过 性，平稳的释放和可靠的锚定等特点。金仕生物自主创新的干瓣技术，在国内、欧洲、美国、日本等国家 享有专利保护。这一产品的出现，迎来中国TAVR的新时代 ——干瓣时代。 艾柯医疗 全新血流导向密网支架系统"Lattice COUPLE"成功获批 近日，艾柯医疗全新血流导向密网支架系统"Lattice COUPLE"，成功获得国家药监局批准注册 （ 注册证编 号：国械注准20253130668） 。至此， 艾柯医疗成为神经介入行业首家拥有三张密网注册证的企业 。 微光医疗 FDA 首次批准中国高端腔内介入影像设备 4月11日，微光医疗宣布其两款冠脉OCT设备及 ...